Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Bayer
- Enrollment
- 6
- Primary Endpoint
- Evaluation of 2 hours water resistant SPF
Study Overview
Brief Summary
Evaluation of the effectiveness of a sunscreen product by determining its Sun Protection Factor (SPF) on the skin of human subjects.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 70 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Male or female of an age of 18 to 70 years inclusive;
- •Fitzpatrick Skin Type I, II and/or III for SPF testing;
- •Good health as determined from the CRO Subject History Form (SHF);
- •Signed and dated Informed Consent Form;
- •Signed and dated Health Insurance Portability and Accountability Act (HIPAA) Form;
- •An unambiguous minimal erythema dose (MED).
Exclusion Criteria
- Not provided
Arms & Interventions
SPF evaluation
Subjects with good health as determined from the CRO Subject History Form (SHF) and Fitzpatrick Skin Type I, II and/or III were included for SPF testing.
Intervention: BAY 987519 (Drug)
SPF evaluation
Subjects with good health as determined from the CRO Subject History Form (SHF) and Fitzpatrick Skin Type I, II and/or III were included for SPF testing.
Intervention: SPF 15 Control (Drug)
Outcomes
Primary Outcomes
Evaluation of 2 hours water resistant SPF
Time Frame: 16-24 h post exposure
ISO/COLIPA Sun Protection FactorTest Method.
Secondary Outcomes
No secondary outcomes reported
